AEMD — Aethlon Medical Share Price
0.000.00%
Last trade - 00:00- $6.11m
- -$2.96m
- 15
- 42
- 14
- 13
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.7 | ||
| Price to Tang. Book | 0.7 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -127.6% | ||
| Return on Equity | -105.38% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.65 | 0.66 | 0.29 | 0.57 | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Directors
- Edward Broenniman NEC (85)
- Charles Fisher CEO (75)
- James Frakes CFO (64)
- Guy Cipriani SVP (51)
- Steven Larosa OTH (54)
- Sabrina Johnson IND (55)
- Chetan Shah IND (52)
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- April 17th, 1991
- Public Since
- March 9th, 1994
- No. of Shareholders
- 62
- No. of Employees
- 14
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 13,937,327
- Address
- 11555 Sorrento Valley Road, Suite 203, SAN DIEGO, 92121
- Web
- https://www.aethlonmedical.com/
- Phone
- +1 6199410360
- Contact
- Susan Noonan
- Auditors
- BAKER TILLY US LLP
Upcoming Events for AEMD
Q3 2025 Aethlon Medical Inc Earnings Release
Similar to AEMD
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
Applied DNA Sciences
NASDAQ Capital Market
FAQ
What is the Aethlon Medical share price?
As of Today at 19:05 UTC, shares in Aethlon Medical are trading at $0.44. This share price information is delayed by 15 minutes.
How has the Aethlon Medical share price performed this year?
Shares in Aethlon Medical last closed at $0.44 and the price had moved by -74.95% over the past 365 days. In terms of relative price strength the Aethlon Medical share price has underperformed the S&P500 Index by -81.23% over the past year.
What are the analyst and broker recommendations for Aethlon Medical?
The overall consensus recommendation for Aethlon Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Aethlon Medical dividend yield?
Aethlon Medical does not currently pay a dividend.
Does Aethlon Medical pay a dividend?
Aethlon Medical does not currently pay a dividend.
When does Aethlon Medical next pay dividends?
Aethlon Medical does not currently pay a dividend.
How do I buy Aethlon Medical shares?
To buy shares in Aethlon Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aethlon Medical?
As of the previous close price of $0.44, shares in Aethlon Medical had a market capitalisation of $6.11m.
Where are Aethlon Medical shares listed?
Here are the trading details for Aethlon Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AEMD
What kind of share is Aethlon Medical?
Based on an overall assessment of its quality, value and momentum Aethlon Medical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aethlon Medical share price forecast for 2024?
The analyst consensus target price for shares in Aethlon Medical is $3.86. That is 780.47% above the last closing price of $0.44.
Analysts covering Aethlon Medical currently have a consensus Earnings Per Share (EPS) forecast of -$1.02 for the next financial year.
Find out moreWhat is the trend in the Aethlon Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aethlon Medical. Over the past six months, its share price has underperformed the S&P500 Index by -77.34%.
As of the last closing price of $0.44, shares in Aethlon Medical were trading -59.17% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aethlon Medical PE Ratio?
The Aethlon Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aethlon Medical?
Aethlon Medical's management team is headed by:
- Edward Broenniman - NEC
- Charles Fisher - CEO
- James Frakes - CFO
- Guy Cipriani - SVP
- Steven Larosa - OTH
- Sabrina Johnson - IND
- Chetan Shah - IND